Rigel Pharmaceuticals, Inc. (RIGL): Price and Financial Metrics

RIGL POWR Grades

• RIGL scores best on the Quality dimension, with a Quality rank ahead of 85.5% of US stocks.
• The strongest trend for RIGL is in Growth, which has been heading up over the past 179 days.
• RIGL's current lowest rank is in the Stability metric (where it is better than 3.48% of US stocks).

RIGL Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for RIGL is -4.51 -- better than only 2.99% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 40.99 for RIGEL PHARMACEUTICALS INC; that's greater than it is for 99.05% of US stocks.
• Over the past twelve months, RIGL has reported earnings growth of 699.35%, putting it ahead of 97.39% of US stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to RIGEL PHARMACEUTICALS INC are AZYO, INTZ, PBYI, ARAY, and EXTR.
• Visit RIGL's SEC page to see the company's official filings. To visit the company's web site, go to www.rigel.com.

RIGL Valuation Summary

• RIGL's price/sales ratio is 1.5; this is 25% lower than that of the median Healthcare stock.
• RIGL's price/sales ratio has moved down 2.6 over the prior 243 months.

Below are key valuation metrics over time for RIGL.

RIGL Growth Metrics

Its 2 year price growth rate is now at 26.53%.
• Its 2 year net income to common stockholders growth rate is now at -202.5%.
• Its 4 year net income to common stockholders growth rate is now at 59.47%.

RIGL's revenue has moved up $30,085,000 over the prior 33 months.

The table below shows RIGL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	89.373	-70.935	-82.615
2022-06-30	88.506	-67.931	-84.53
2022-03-31	84.953	0.196	-84.859
2021-12-31	149.236	5.878	-17.914
2021-09-30	147.277	9.392	-14.51
2021-06-30	144.123	0.207	-7.732

RIGL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RIGL has a Quality Grade of B, ranking ahead of 89.87% of graded US stocks.
• RIGL's asset turnover comes in at 0.825 -- ranking 30th of 682 Pharmaceutical Products stocks.
• GERN, NEOG, and VNDA are the stocks whose asset turnover ratios are most correlated with RIGL.

The table below shows RIGL's key quality metrics over time.